The role of potassium channels in the inhibitory effects of beta 2-adrenoceptor agonists on DNA synthesis in human cultured airway smooth muscle

Pulm Pharmacol Ther. 1997;10(2):71-9. doi: 10.1006/pupt.1997.0077.

Abstract

Opening of calcium-dependent K+ channels by beta 2-adrenoceptor agonists has been shown to contribute to their smooth muscle relaxant activity. In this study, the influence of K+ channel activity on human cultured airway smooth muscle proliferation and on its inhibition by salbutamol have been examined. Studies of 86Rb+ efflux from the airway smooth muscle cell cultures confirmed that both cromakalim, an activator of ATP-dependent K+ channels and salbutamol increased K+ channel activity in cultured airway smooth muscle. The efflux of 86Rb+ was significantly attenuated by non-specific K+ channel blockade. Potassium channel blockers had only small and variable effects on [3H]-thymidine incorporation in unstimulated cells and those stimulated with fetal calf serum (FCS) and no effect on FCS-induced increases in cell number. Potassium channel openers also had no substantial inhibitory effects on DNA synthesis or proliferation in cells stimulated with other mitogens including thrombin. Blockade of K+ channels had no consistent effects on the inhibition of DNA synthesis and cell proliferation caused by salbutamol (0.3 nM-10 microM). The inhibition of DNA synthesis caused by 8 bromoadenosine 3'5' cyclic monophosphate (1 microM-1 mM) or 8 bromoguanosine 3'5' cyclic monophosphate (1 microM-1 mM) was also unaffected by K+ channel blockade. These results indicate that changes in K+ channel activity have no detectable influence on DNA synthesis and proliferation of human cultured airway smooth muscle cells or on the antiproliferative effects of beta 2-agonists.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adrenergic beta-2 Receptor Agonists*
  • Adrenergic beta-Agonists / pharmacology*
  • Adult
  • Aged
  • Albuterol / pharmacology
  • Bronchi / drug effects*
  • Bronchi / metabolism
  • Cell Division / drug effects
  • Cells, Cultured
  • Cromakalim / pharmacology
  • Cyclic AMP / metabolism
  • DNA / biosynthesis
  • Humans
  • Middle Aged
  • Muscle, Smooth / drug effects*
  • Muscle, Smooth / metabolism
  • Potassium Channels / physiology*
  • Receptors, Adrenergic, beta-2 / physiology
  • Rubidium / metabolism

Substances

  • Adrenergic beta-2 Receptor Agonists
  • Adrenergic beta-Agonists
  • Potassium Channels
  • Receptors, Adrenergic, beta-2
  • Cromakalim
  • DNA
  • Cyclic AMP
  • Rubidium
  • Albuterol